Belite Bio's top three insider shareholders as of August 29, 2026 are Hao-Yuan Chuang (Chief Financial Officer, 205.26K shares), Hao-Yuan Chuang (Chief Financial Officer, 205.26K shares), Yu-Hsin Lin (Chief Executive Officer, 182.95K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Yu-Hsin Lin | Chief Executive Officer | 353,518 | 0 | 353,518 | 52.3% | 14 Aug, 2026 |
| 2 | Hao-Yuan Chuang | Chief Financial Officer | 298,697 | 0 | 298,697 | 44.2% | 14 Aug, 2026 |
| 3 | Hendrik Peter Scholl | Chief Medical Officer | 0 | 15,000 | 15,000 | 2.2% | 22 Jun, 2026 |
| 4 | Wan-Shan Chen | Director | 9,096 | 0 | 9,096 | 1.3% | 13 Apr, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 12 Aug, 2026 | Hao-Yuan Chuang | Chief Financial Officer | Disposed S | 144 | $180.00 | $25.92K | 93,656 | Direct |
| 12 Aug, 2026 | Yu-Hsin Lin | Chief Executive Officer | Disposed S | 142 | $180.00 | $25.56K | 170,792 | Direct |
| 12 Aug, 2026 | Hao-Yuan Chuang | Chief Financial Officer | Disposed S | 223 | $180.57 | $40.27K | 93,433 | Direct |
| 12 Aug, 2026 | Yu-Hsin Lin | Chief Executive Officer | Disposed S | 223 | $180.57 | $40.27K | 170,569 | Direct |
| 18 Jun, 2026 | Hendrik Peter Scholl | Chief Medical Officer | Disposed S | 96 | $143.90 | $13.81K | 24,904 | Indirect |
| 18 Jun, 2026 | Hendrik Peter Scholl | Chief Medical Officer | Disposed S | 3,748 | $144.66 | $542.19K | 21,156 | Indirect |
| 18 Jun, 2026 | Hendrik Peter Scholl | Chief Medical Officer | Disposed S | 4,861 | $145.43 | $706.96K | 16,295 | Indirect |
| 18 Jun, 2026 | Hendrik Peter Scholl | Chief Medical Officer | Disposed S | 1,199 | $146.24 | $175.35K | 15,096 | Indirect |
| 18 Jun, 2026 | Hendrik Peter Scholl | Chief Medical Officer | Disposed S | 96 | $147.11 | $14.12K | 15,000 | Indirect |
| 16 Jun, 2026 | Hendrik Peter Scholl | Chief Medical Officer | Disposed S | 2,054 | $137.61 | $282.64K | 32,946 | Indirect |
| 16 Jun, 2026 | Hendrik Peter Scholl | Chief Medical Officer | Disposed S | 784 | $138.18 | $108.33K | 32,162 | Indirect |
| 16 Jun, 2026 | Hendrik Peter Scholl | Chief Medical Officer | Disposed S | 3,140 | $139.57 | $438.26K | 29,022 | Indirect |
| 16 Jun, 2026 | Hendrik Peter Scholl | Chief Medical Officer | Disposed S | 540 | $140.58 | $75.91K | 28,482 | Indirect |
| 16 Jun, 2026 | Hendrik Peter Scholl | Chief Medical Officer | Disposed S | 100 | $141.83 | $14.18K | 28,382 | Indirect |
| 16 Jun, 2026 | Hendrik Peter Scholl | Chief Medical Officer | Disposed S | 450 | $142.20 | $63.99K | 27,932 | Indirect |
| 16 Jun, 2026 | Hendrik Peter Scholl | Chief Medical Officer | Disposed S | 1,897 | $143.55 | $272.31K | 26,035 | Indirect |
| 16 Jun, 2026 | Hendrik Peter Scholl | Chief Medical Officer | Disposed S | 1,035 | $145.02 | $150.10K | 25,000 | Indirect |
| 07 May, 2026 | Nathan L. Mata | Chief Scientific Officer | Disposed S | 226 | $152.45 | $34.45K | 440 | Direct |
| 07 May, 2026 | Nathan L. Mata | Chief Scientific Officer | Disposed S | 428 | $153.56 | $65.73K | 12 | Direct |
| 07 May, 2026 | Nathan L. Mata | Chief Scientific Officer | Disposed S | 3 | $154.61 | $464 | 9 | Direct |